Skip to main content

Table 2 Clinical characteristics and diagnosis of 12 patients

From: Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy

Clinical characteristics

n = 12

 Male/female

5/7

 Age at initial visit [years]

62 (47–75)

 Acute onset/chronic onset

8/4

 Smoking status (current or former/never smoker)

6/6

Serological findings (reference value)

n = 12

 CK [U/L] (62–287)

140 (17–672)

 LDH [U/L] (70–139)

252 (212–337)

 ESR [mm/h] (2–10)

38 (17–116)

 CRP [mg/dl] (0–0.1)

0.63 (0.03–1.79)

 KL-6 [U/ml] (0–500)

991 (514–3208)

 SP-D [ng/ml] (0–110)

232.3 (56.1–723.1)

 PaO2 [Torr] (74–108)

71.5 (53.0–84.5)

Pulmonary functions

n = 11

 FVC % predicted [%]

71.5 (42.4–86.1)

 DLCO % predicted [%]

66.1 (56.0–112.2)

  1. Data are presented as n, or median (range)
  2. CK: Creatine kinase, LDH: Lactate dehydrogenase, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, KL-6: Klebs von den lungen-6, SP-D: Surfactant protein D, PaO 2 : Arterial oxygen pressure, FVC: Forced vital capacity, DL CO : Diffusion capacity for carbon monoxide